secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edwards Lifesciences Corp (EW)
CIK:        0001099800
Form:       8-K
Filed at:   2022-05-04T23:59:59+00:00
Accession:  0001193125-22-140622
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Edwards Lifesciences holds 2022 annual meeting; all director nominees elected
-----------------------------------------------------------------------------

- All 8 director nominees elected, including Kieran T. Gallahue, Leslie H. Heisz, Paul A. LaViolette, and others.
- Say-on-pay advisory proposal approved with 450M for, 49.9M against, 1.5M abstain.
- Ratification of PwC as auditor for FY2022 approved with 503M for, 31.9M against.
- Shareholder proposal to reduce special meeting ownership threshold failed with 181.6M for, 315M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1099800/000119312522140622/0001193125-22-140622-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1099800/000119312522140622/d346854d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-140622

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer